🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ELCC24 Poster describing outcomes with 2L therapy after 1L chemo-immunotherapy in #SCLC. 31% lurbinectedin, 21%, EP rechallenge, 9% topotecan. Survival similar in rechallenge vs other. Only 23% go on to 3L. #ESMOAmbasaadors ESMO - Eur. Oncology IASLC

Posting ahead of International Transgender Day of Visibility (tdov.org.au) 31 Mar 24 WEHI (Walter and Eliza Hall Institute) Illuminarium lit up in support! Trans people have unique challenges w/ cancer journey Cancer Council Victoria. Collective work & allyship needed cancervic.org.au/cancer-informa…

If you like to read final versions - this was just posted: Commentary on SMARCA4-deficient undifferentiated tumors mimicking small cell carcinoma. doi.org/10.1158/1078-0… Original paper by Sutherland Lab and Jin Ng, PhD doi.org/10.1158/1078-0…

Press release: phase III ADRIATIC study of durvalumab after chemoradiation for limited stage #SCLC improves both PFS and OS. Follows the PACIFIC approach, randomizing after definitive chemoradiation. Await data on durva + tremelimumab arm. #LCSM astrazeneca.com/media-centre/p…

Great to see this #lungcancer screening programme rolled out in London, UK. Looking forward to seeing Australian National Lung Cancer Screening Program being rolled out next year Lung Foundation Australia

Pleased to see this work on patient-derived xenograft methods and protocols published. Thanks to all authors for their valuable contributions to this book! Special thanks to Jin Ng, PhD for the beautiful cover images. Uni of Adelaide South Australian immunoGENomics Cancer Institute Jenkins Lab link.springer.com/book/10.1007/9…

🔬Our protocol investigating #SCLC transcription factor heterogeneity & robust pipeline to quantify images out now!🔬Sutherland Lab WEHI (Walter and Eliza Hall Institute) link.springer.com/protocol/10.10… Thank you for selecting our pictures for the cover of this book Mohamed I. Saad, super honoured!

Stoked to get an invited spot speaking about our work on gamma delta T cells and #SCLC at Immuno-Oncology 2024 in London Cambridge Healthtech Institute Very cool emerging therapeutics on making immune-"cold" solid tumours, "hot". Thanks The CASS Foundation for the Travel Award towards this

Interesting multi-omic analysis of previously classified SCLC cell lines (YAP1+), identifies that these tumors represent diseases that ‘mimic’ SCLC- in this case- SMARCA4-deficient thoracic tumors, that have a poor prognosis Clinical Cancer Research OncoAlert #LCSM aacrjournals.org/clincancerres/…

Groundbreaking study by Sutherland Lab and colleagues challenging the dogma of “YAP1” neuroendocrine subtype in #SCLC. This research finally clarifies how YAP1+ actually appears in SMARCA4-deficient undifferentiated thoracic tumors, not in #SCLC. #LCSM #researchcurescancer

Great honor to write this commentary on your fantastic study, Sutherland Lab and Jin Ng, PhD!

Congratulations Jin Ng, PhD 🤩on his CASS Foundation grant to accelerate translational studies on #SCLC! WEHI (Walter and Eliza Hall Institute) WEHI Postdocs

First grant as CIA unlocked! Very fortunate to receive this grant from The CASS Foundation towards generating SCLC patient-derived organoids for personalised therapy approaches.

Today marks my first official day as Senior Research Officer (Level B) in the Sutherland Lab at WEHI (Walter and Eliza Hall Institute)! View from the office today with a slither of sunshine poking through

Sweet success!! Our PhD student Lingshuang Chen in Sutherland Lab Marian Burr WEHI (Walter and Eliza Hall Institute) winning Runner Up for her 3 minute thesis on #SCLC mets! Watch this space! #WEHI3MT

1 Hot off the press from team Memorial Sloan Kettering Cancer Center in Cancer Discovery! A study solving the puzzle of exceptional new lung cancer type: #Chromothripsis-mediated Small Cell Lung Cancer #SCLC This took nearly a decade and 42 coauthors to unravel. Here are some highlights 👇

Immune cell landscape changes upon gender affirming hormone therapy. Considerations for trans/gender-diverse patients receiving any sort of standard of care very important. 🏳️‍⚧️🏳️‍⚧️🏳️‍⚧️

Very honoured to be shortlisted for the Research Australia Discovery Award for our recent work aacrjournals.org/clincancerres/… Couldn't have done this without my awesome mentors and nominators Sutherland Lab and Marian Burr, the clinicians, bioinformaticians and researchers involved! 🏳️‍🌈🔬

Thanks again Research Australia for the recognition of our work! This is especially meaningful during Lung Cancer Awareness Month in November 🎗️🫁

Congrats to Dr Jin Ng, PhD, who was highly commended in Research Australia's Discovery Award! 🏆 This recognition honours his groundbreaking discovery, paving the way to better identify lung cancer patients likely to benefit from immunotherapy. Read more 👉 wehi.edu.au/news/advancing…